193 related articles for article (PubMed ID: 30624716)
1. Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides.
Martins RP; Malbert-Colas L; Lista MJ; Daskalogianni C; Apcher S; Pla M; Findakly S; Blondel M; Fåhraeus R
Nucleic Acids Res; 2019 Apr; 47(6):3086-3100. PubMed ID: 30624716
[TBL] [Abstract][Full Text] [Related]
2. Pioneer translation products as an alternative source for MHC-I antigenic peptides.
Apcher S; Daskalogianni C; Fåhraeus R
Mol Immunol; 2015 Dec; 68(2 Pt A):68-71. PubMed ID: 25979818
[TBL] [Abstract][Full Text] [Related]
3. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
[TBL] [Abstract][Full Text] [Related]
4. MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation.
Weinstein-Marom H; Hendel L; Laron EA; Sharabi-Nov A; Margalit A; Gross G
FASEB J; 2019 Oct; 33(10):11458-11468. PubMed ID: 31343935
[TBL] [Abstract][Full Text] [Related]
5. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.
Apcher S; Daskalogianni C; Lejeune F; Manoury B; Imhoos G; Heslop L; Fåhraeus R
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11572-7. PubMed ID: 21709220
[TBL] [Abstract][Full Text] [Related]
6. Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
Reznichenko O; Quillévéré A; Martins RP; Loaëc N; Kang H; Lista MJ; Beauvineau C; González-García J; Guillot R; Voisset C; Daskalogianni C; Fåhraeus R; Teulade-Fichou MP; Blondel M; Granzhan A
Eur J Med Chem; 2019 Sep; 178():13-29. PubMed ID: 31173968
[TBL] [Abstract][Full Text] [Related]
7. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway.
Apcher S; Millot G; Daskalogianni C; Scherl A; Manoury B; Fåhraeus R
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17951-6. PubMed ID: 24082107
[TBL] [Abstract][Full Text] [Related]
8. mRNA translation from an antigen presentation perspective: A tribute to the works of Nilabh Shastri.
Apcher S; Tovar-Fernadez M; Ducellier S; Thermou A; Nascimento M; Sroka E; Fahraeus R
Mol Immunol; 2022 Jan; 141():305-308. PubMed ID: 34920325
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of MHC class I antigenic peptides in the nucleus: a role for the nuclear translation at last?].
Duvallet E; Boulpicante M; Apcher S
Med Sci (Paris); 2014 Mar; 30(3):229-31. PubMed ID: 24685205
[No Abstract] [Full Text] [Related]
10. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
Lista MJ; Martins RP; Billant O; Contesse MA; Findakly S; Pochard P; Daskalogianni C; Beauvineau C; Guetta C; Jamin C; Teulade-Fichou MP; Fåhraeus R; Voisset C; Blondel M
Nat Commun; 2017 Jul; 8():16043. PubMed ID: 28685753
[TBL] [Abstract][Full Text] [Related]
11. Effects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex-I mediated antigen presentation.
Murat P; Tellam J
Wiley Interdiscip Rev RNA; 2015; 6(2):157-71. PubMed ID: 25264139
[TBL] [Abstract][Full Text] [Related]
12. Harnessing short poly(A)-binding protein-interacting peptides for the suppression of nonsense-mediated mRNA decay.
Fatscher T; Gehring NH
Sci Rep; 2016 Nov; 6():37311. PubMed ID: 27874031
[TBL] [Abstract][Full Text] [Related]
13. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.
Powers CJ; Früh K
PLoS Pathog; 2008 Oct; 4(10):e1000150. PubMed ID: 18833297
[TBL] [Abstract][Full Text] [Related]
14. Antigenic peptides: Reviving nuclear translation.
Van Damme P; Menschaert G
Nat Chem Biol; 2013 Dec; 9(12):759-60. PubMed ID: 24231616
[No Abstract] [Full Text] [Related]
15. Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway.
Duvallet E; Boulpicante M; Yamazaki T; Daskalogianni C; Prado Martins R; Baconnais S; Manoury B; Fahraeus R; Apcher S
Oncoimmunology; 2016; 5(9):e1198865. PubMed ID: 27757298
[TBL] [Abstract][Full Text] [Related]
16. Expression of MHC class I molecules together with antigenic peptides on filamentous phages.
Kurokawa MS; Ohoka S; Matsui T; Sekine T; Yamamoto K; Nishioka K; Kato T
Immunol Lett; 2002 Mar; 80(3):163-8. PubMed ID: 11803048
[TBL] [Abstract][Full Text] [Related]
17. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.
Murat P; Zhong J; Lekieffre L; Cowieson NP; Clancy JL; Preiss T; Balasubramanian S; Khanna R; Tellam J
Nat Chem Biol; 2014 May; 10(5):358-64. PubMed ID: 24633353
[TBL] [Abstract][Full Text] [Related]
18. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.
Praest P; Liaci AM; Förster F; Wiertz EJHJ
Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337
[TBL] [Abstract][Full Text] [Related]
19. A distinct translation initiation mechanism generates cryptic peptides for immune surveillance.
Starck SR; Ow Y; Jiang V; Tokuyama M; Rivera M; Qi X; Roberts RW; Shastri N
PLoS One; 2008; 3(10):e3460. PubMed ID: 18941630
[TBL] [Abstract][Full Text] [Related]
20. The synthesis of truncated polypeptides for immune surveillance and viral evasion.
Cardinaud S; Starck SR; Chandra P; Shastri N
PLoS One; 2010 Jan; 5(1):e8692. PubMed ID: 20098683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
